ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 67 filers reported holding ACELRX PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 2.10 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $0 | – | 4 | 0.0% | 0.00% | – |
| Q2 2022 | $0 | – | 4 | 0.0% | 0.00% | – |
| Q1 2022 | $0 | -100.0% | 4 | -99.8% | 0.00% | – |
| Q4 2021 | $1,000 | -99.8% | 1,842 | -99.6% | 0.00% | – |
| Q3 2021 | $450,000 | -9.3% | 441,956 | +23.1% | 0.00% | – |
| Q2 2021 | $496,000 | -59.7% | 359,131 | -50.5% | 0.00% | – |
| Q1 2021 | $1,232,000 | +239.4% | 724,929 | +147.5% | 0.00% | – |
| Q4 2020 | $363,000 | +5.5% | 292,928 | +20.7% | 0.00% | – |
| Q3 2020 | $344,000 | +4200.0% | 242,741 | +3388.2% | 0.00% | – |
| Q2 2020 | $8,000 | +100.0% | 6,959 | +99.7% | 0.00% | – |
| Q1 2020 | $4,000 | -87.1% | 3,485 | -76.7% | 0.00% | – |
| Q4 2019 | $31,000 | 0.0% | 14,956 | +7.0% | 0.00% | – |
| Q3 2019 | $31,000 | +34.8% | 13,972 | +55.7% | 0.00% | – |
| Q2 2019 | $23,000 | -82.8% | 8,973 | -76.7% | 0.00% | – |
| Q1 2019 | $134,000 | +1814.3% | 38,467 | +1089.5% | 0.00% | – |
| Q4 2018 | $7,000 | 0.0% | 3,234 | -2.0% | 0.00% | – |
| Q4 2017 | $7,000 | -53.3% | 3,300 | 0.0% | 0.00% | – |
| Q3 2017 | $15,000 | -53.1% | 3,300 | -77.9% | 0.00% | – |
| Q2 2017 | $32,000 | -13.5% | 14,964 | +27.7% | 0.00% | – |
| Q1 2017 | $37,000 | +23.3% | 11,719 | +4.1% | 0.00% | – |
| Q4 2016 | $30,000 | +15.4% | 11,262 | +69.0% | 0.00% | – |
| Q3 2016 | $26,000 | +73.3% | 6,664 | +17.6% | 0.00% | – |
| Q2 2016 | $15,000 | 0.0% | 5,668 | +13.4% | 0.00% | – |
| Q1 2016 | $15,000 | -81.5% | 5,000 | -76.1% | 0.00% | – |
| Q4 2015 | $81,000 | +50.0% | 20,947 | +19.0% | 0.00% | – |
| Q3 2015 | $54,000 | -35.7% | 17,600 | -11.1% | 0.00% | – |
| Q2 2015 | $84,000 | +23.5% | 19,789 | +12.1% | 0.00% | – |
| Q1 2015 | $68,000 | -20.9% | 17,658 | +38.0% | 0.00% | – |
| Q4 2014 | $86,000 | +3.6% | 12,800 | -15.1% | 0.00% | – |
| Q3 2014 | $83,000 | -83.9% | 15,069 | -70.0% | 0.00% | – |
| Q2 2014 | $515,000 | +202.9% | 50,224 | +255.3% | 0.00% | – |
| Q1 2014 | $170,000 | -82.9% | 14,135 | -83.9% | 0.00% | – |
| Q4 2013 | $994,000 | +184.0% | 87,920 | +170.8% | 0.00% | – |
| Q3 2013 | $350,000 | -29.1% | 32,467 | -39.1% | 0.00% | – |
| Q2 2013 | $494,000 | – | 53,312 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 6,574,060 | $27,874,000 | 1.68% |
| SENZAR ASSET MANAGEMENT, LLC | 798,381 | $3,385,000 | 0.58% |
| Cormorant Asset Management, LP | 850,000 | $3,604,000 | 0.48% |
| Palo Alto Investors LP | 2,135,739 | $9,056,000 | 0.40% |
| Opus Point Partners Management, LLC | 99,959 | $424,000 | 0.34% |
| Granahan Investment Management | 1,582,237 | $6,709,000 | 0.19% |
| Joel Isaacson & Co., LLC | 70,660 | $300,000 | 0.08% |
| MARINER INVESTMENT GROUP LLC | 59,700 | $253,000 | 0.06% |
| MYCIO WEALTH PARTNERS, LLC | 75,000 | $318,000 | 0.06% |
| Cornerstone Capital, Inc. | 59,200 | $251,000 | 0.06% |